Please login to the form below

Not currently logged in
Email:
Password:

Daily Brief: EULAR kicks off, Brexit lurches closer and Autolus prepares for IPO

A rapid round up of today's pharma, biotech and healthcare news

AmsterdamHello and welcome to another round up from the world of pharma, biotech and healthcare.

Today sees the European League Against Rheumatism (EULAR) congress kick off in Amsterdam, with all the big players presenting data over the next few days.

On today’s agenda expect new trial data from Novartis' Ilaris in gout, Lilly's Oluminant in systemic lupus and AbbVie's new JAK inhibitor upadacitinib.

Read more here

Brexit

Yesterday saw Theresa May's government narrowly win some crucial votes in Parliament on Brexit, managing to bring together its warring remainers and brexiteer factions. There is little agreement about what promises the government has made about MPs signing off any deal, with some concluding that a 'No Deal' Brexit is impossible - but others not so sure.

Read more from The Guardian here

Autolus aims for $117m IPO

Autolus, one of the UK's most hotly-topped private biotech is preparing to launch its IPOS on the Nasdaq, and expects to raise $117-132m.

The company is working on several next-generation CAR-T drugs, including one candidate in the competitive BCMA-targeting niche for multiple myeloma.

Autolus has just launched a roadshow to inform investors about its IPO and pipeline, and has also just made two senior appointments.

Linda Bain

Andrew Oakley had been appointed the firm's new chief financial officer, joining Sosei Group where he served as its executive vice president and chief financial officer since February 2017.

Also joining the board of directors is Linda Bain (pictured). She has over 20 years of finance and audit experience in biotech and pharma.

Bain currently serves as Chief Financial Officer of Codiak BioSciences, a privately held company in the emerging field of exosome therapeutics.

Article by
Andrew McConaghie

13th June 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics